On the heels of Time Warner’s rejection of an unsolicated takeover bid from Rupert Murdoch’s 21st Century Fox , here’s a look at how companies politely tell potential buyers to get lost.
Begin by stating your "careful evaluation" of the proposal in question.
"The Men's Wearhouse today announced that its Board of Directors, after careful evaluation with the assistance of its financial and legal advisors, has determined to reject an unsolicited, non-binding proposal from Jos. A. Bank."
— Men's Wearhouse
October 9, 2013
"After a comprehensive review, conducted in consultation with its financial and legal advisors, the Allergan Board concluded..."
— Allergan
May 12, 2014
"After carefully reviewing your offer with our financial and legal advisors, we continue to believe that your offer to acquire Jos. A. Bank..."
— Jos. A. Bank
February 2, 2014
Via whatshouldwecallweddingphoto.tumblr.com
But be sure to throw some shade right away.
"Time Warner Cable Inc. said today that its Board of Directors has unanimously rejected a third grossly inadequate proposal from Charter Communications to acquire TWC. The proposal was described only generally in a letter received today from Charter as being in the 'low $130s.'"
— Time Warner Cable
January 13, 2014
"We are confident that we can achieve total shareholder returns well in excess of what can be derived from Jos. A. Bank's unsolicited and inadequate proposal."
— Men's Wearhouse
October 9, 2013
"Darden strongly believes that Starboard's special meeting is an unsatisfactory alternative to direct, ongoing engagement between the Company and its shareholders regarding the Company's strategic direction and other matters of interest to shareholders."
— Darden to Starboard Value
March 19, 2014
"[The Cadbury board]emphatically rejected this derisory offer."
— Cardbury to Kraft
November 10, 2009
Determine whether the offer "significantly" or "substantially" undervalues your company.
"First and foremost, it substantially undervalues TWC and would represent an EBITDA multiple of approximately 7X, well below past transactions in the cable sector."
— Time Warner Cable to Charter
January 13, 2014
"After careful review and consideration, our Board of Directors has unanimously determined that Valeant's unsolicited proposal substantially undervalues Allergan."
— Allergan
May 12, 2014
"The Men's Wearhouse Board believes that Jos. A. Bank's proposal significantly undervalues Men's Wearhouse."
— Men's Wearhouse
October 9, 2013
"As you may be aware, Endurance Specialty Holdings Ltd. recently became a shareholder of your Company and has filed a solicitation statement seeking shareholder support for certain tactics intended to facilitate its unsolicited offer to acquire all of the outstanding shares of Aspen Insurance Holdings Limited in exchange for consideration that the Aspen board of directors has repeatedly and unanimously determined significantly undervalues Aspen."
— Aspen Health Insurance
June 27, 2013
Via tumblr.com
Make sure everyone knows how risky this would be.
"There is significant risk and uncertainty as to the valuation of Twenty-First Century Fox's non-voting stock and Twenty-First Century Fox's ability to govern and manage a combination of the size and scale of Twenty-First Century Fox and Time Warner; and there are considerable strategic, operational, and regulatory risks to executing a combination with Twenty-First Century Fox."
— Time Warner
July 16, 2014
"Furthermore, the Board has determined that Valeant's proposal creates significant risks and uncertainties for Allergan's stockholders and believes that the Valeant business model is not sustainable."
— Allergan
May 12, 2014
"We believe Jos. A. Bank's unsolicited proposal is opportunistic, subject to unacceptable risks and contingencies, and would deprive our shareholders of the value inherent in Men's Wearhouse for inadequate consideration."
— Men's Wearhouse
October 9, 2013
"We have rejected Pfizer's final proposal because it is inadequate and would present significant risks for shareholders, while also having serious consequences for the company, our employees and the life-sciences sector in the UK, Sweden and the US."
— Astrazeneca
May 19, 2014
Via giphy.com
via IFTTT
No comments:
Post a Comment